An investment fund sets out to free biotech’s ‘trapped capital’

3 days ago

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund”…

4 days ago

Sanofi, Regeneron win FDA nod for Dupixent in chronic hives

The partners overcame an earlier rejection to win a seventh use for Dupixent, though some analysts are skeptical of its…

5 days ago

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about $29 million…

1 week ago

The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals…

2 weeks ago

The bispecific antibody helped people with small cell lung cancer live longer, Amgen said. Elsewhere, J&J shared new autoimmune drug…

2 weeks ago

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the…

2 weeks ago

“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the…

3 weeks ago

Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, threatening to create disruptions to patient care.

3 weeks ago

Sarepta and Roche will share the monitors' findings with EMA to resolve a temporary hold. Elsewhere, Allakos agreed to a…

3 weeks ago

The president will impose a baseline 10% tariff on all countries, as well as higher levies on certain nations. Pharmaceutical…